Clinical Trial Update: Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib Vaccine Followed by the Same Vaccine and Oral Polio Vaccine [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the immunogenicity and reactogenicity of the DTPa-HBV-IPV/Hib vaccine given in a schedule with subsequent vaccination and oral p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Haemophilus Influenzae Type Disease
• Hepatitis B
• Pertussis
• Poliomyelitis
• Tetanus

Drugs mentioned

• Infanrix Hexa (DTPa-HBV-IPV/Hib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B, Acellular Pertussis | Phase 3 | Status: COMPLETED